This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Carcinoma, Ehrlich Tumor
Information about Carcinoma, Ehrlich Tumor: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Carcinoma, Ehrlich Tumor
Most recent studies have shown that Carcinoma, Ehrlich Tumor shares some biological mechanisms with carcinoma, carcinoma-256-walker, depression-chemical, leukemia, leukemia-experimental, leukemia-l1210, liver-carcinoma, liver-neoplasms, lymphoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, mammary-neoplasms-experimental, neoplasm-metastasis, neoplasms, neoplasms-experimental, sarcoma, sarcoma-180, sarcoma-experimental, sarcoma-yoshida.
Among the many pathways, these few ones have gauged particular interests from scientists studying Carcinoma, Ehrlich Tumor, and have been seen in publications frequently: Amino Acid Transport, Angiogenesis, Cell Cycle, Cell Death, Cell Division, Cell Growth, Cell Proliferation, Dna Replication, Excretion, Glycolysis, Immune Response, Interphase, Localization, Methylation, Mitosis, Oxidative Phosphorylation, Phagocytosis, S Phase, Translation, Transport
Quite a number of genes have been found to play important roles in Carcinoma, Ehrlich Tumor, such as ALB, CALM1, CALM2, CALM3, CASP3, CAT, CEL, CYLD, DHFR, EGF, GLS, GSR, IL2, INS, ODC1, SOD1, TNF, TYMS, VEGFA, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.